Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 3/2018

01-06-2018 | Research Article

Venous thromboembolism prophylaxis in mental health in-patient services: a qualitative study

Authors: Audrey Purcell, Mary Clarke, Ian Maidment

Published in: International Journal of Clinical Pharmacy | Issue 3/2018

Login to get access

Abstract

Background Venous thromboembolism (VTE) is an important and potentially preventable cause of morbidity and mortality in hospitalised patients. It is a significant, international patient safety issue affecting medical, surgical and mental health in-patients. There is a paucity of published evidence on the incidence of VTE, and the role of VTE risk-assessment and prophylaxis, in mental healthcare settings. Epidemiological evidence indicates that antipsychotic medications are an independent risk factor for VTE. Objective To explore healthcare practitioners’ experiences and perspectives regarding VTE prophylaxis for in-patients in mental health services in Ireland. Setting This study was conducted in two national teaching hospitals in Dublin, Ireland. Method This experiential, qualitative study was conducted using face-to-face, semi-structured interviews. Purposive sampling was used to allow strategic selection of participants from the pharmacy, medical and nursing disciplines. Data was analysed using inductive thematic analysis. Consolidated criteria for reporting qualitative studies guidelines were used as a reporting framework. Main outcome measure Participants’ views on VTE prophylaxis for mental health in-patients. Results Five key themes were derived: risk factors in mental health, attitudes to risk-assessment, challenges with VTE prophylaxis, lack of awareness, and lack of evidence in mental health. Conclusion The results indicate considerable diversities in perceived risk of VTE, and in experiences with VTE risk-assessment and prophylaxis. VTE risk was considered in practice specifically for immobile, older adults and eating disorder patients on bed rest. Specific research is required to address this area of clinical uncertainty in mental health.
Appendix
Available only for authorised users
Literature
2.
go back to reference Raskob GE, Angchaisuksiri P, Blanco AN, Buller H, Gallus A, Hunt BJ, et al. Thrombosis: a major contributor to global disease burden. Arterioscler Thromb Vasc Biol. 2014;34:2363–71.CrossRefPubMed Raskob GE, Angchaisuksiri P, Blanco AN, Buller H, Gallus A, Hunt BJ, et al. Thrombosis: a major contributor to global disease burden. Arterioscler Thromb Vasc Biol. 2014;34:2363–71.CrossRefPubMed
4.
go back to reference Hippsley-Cox J, Coupland C. Development and validation of risk prediction algorithm (QThrombosis) to estimate future risk of venous thromboembolism: prospective cohort study. BMJ. 2011;343:d4656.CrossRef Hippsley-Cox J, Coupland C. Development and validation of risk prediction algorithm (QThrombosis) to estimate future risk of venous thromboembolism: prospective cohort study. BMJ. 2011;343:d4656.CrossRef
6.
go back to reference Barbui C, Conti V, Cipriani A. Antipsychotic drug exposure and risk of venous thromboembolism: a systematic review and meta-analysis of observational studies. Drug Saf. 2014;37:79–90.CrossRefPubMed Barbui C, Conti V, Cipriani A. Antipsychotic drug exposure and risk of venous thromboembolism: a systematic review and meta-analysis of observational studies. Drug Saf. 2014;37:79–90.CrossRefPubMed
7.
go back to reference Masopust J, Maly R, Valis M. risk of venous thromboembolism during treatment with antipsychotic agents. Psychiatry Clin Neurosci. 2012;66:541–52.CrossRefPubMed Masopust J, Maly R, Valis M. risk of venous thromboembolism during treatment with antipsychotic agents. Psychiatry Clin Neurosci. 2012;66:541–52.CrossRefPubMed
8.
go back to reference Zhang R, Dong L, Shao F, Tan X, Ying K. Antipsychotics and venous thromboembolism risk: a meta-analysis. Pharmacopsychiatry. 2011;44:183–8.CrossRefPubMed Zhang R, Dong L, Shao F, Tan X, Ying K. Antipsychotics and venous thromboembolism risk: a meta-analysis. Pharmacopsychiatry. 2011;44:183–8.CrossRefPubMed
9.
go back to reference Parker C, Coupland C, Hippisley-Cox J. Antipsychotic drugs and risk of venous thromboembolism: nested case-control study. BMJ. 2010;341:c4245.CrossRefPubMed Parker C, Coupland C, Hippisley-Cox J. Antipsychotic drugs and risk of venous thromboembolism: nested case-control study. BMJ. 2010;341:c4245.CrossRefPubMed
10.
go back to reference Hagg S, Bate A, Stahl M, Spigset O. Associations between venous thromboembolism and antipsychotics. A study of the WHO database of adverse drug reactions. Drug Saf. 2008;31(8):685–94.CrossRefPubMed Hagg S, Bate A, Stahl M, Spigset O. Associations between venous thromboembolism and antipsychotics. A study of the WHO database of adverse drug reactions. Drug Saf. 2008;31(8):685–94.CrossRefPubMed
12.
go back to reference Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32 item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19:349–57.CrossRefPubMed Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32 item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19:349–57.CrossRefPubMed
13.
go back to reference Braun V, Clarke V. Successful qualitative research, a practical guide for beginners. London: SAGE Publications Ltd; 2013. Braun V, Clarke V. Successful qualitative research, a practical guide for beginners. London: SAGE Publications Ltd; 2013.
14.
go back to reference Cowen P, Harrison P, Burns T. Shorter oxford textbook of psychiatry. 6th ed. Oxford: Oxford University Press; 2012.CrossRef Cowen P, Harrison P, Burns T. Shorter oxford textbook of psychiatry. 6th ed. Oxford: Oxford University Press; 2012.CrossRef
16.
go back to reference Jenkinson J. A critical analysis of VTE prophylaxis in psychiatric patients. Poster presentation. Royal College of Psychiatrists’ International Congress; 2012. Jenkinson J. A critical analysis of VTE prophylaxis in psychiatric patients. Poster presentation. Royal College of Psychiatrists’ International Congress; 2012.
18.
go back to reference McFarland L, Murray E, Harrison S, Heneghan C, Ward A, Fitzmaurice D, et al. Current practice of venous thromboembolism prevention in acute trusts: a qualitative study. BMJ Open. 2014;4(6):e005074.CrossRefPubMedPubMedCentral McFarland L, Murray E, Harrison S, Heneghan C, Ward A, Fitzmaurice D, et al. Current practice of venous thromboembolism prevention in acute trusts: a qualitative study. BMJ Open. 2014;4(6):e005074.CrossRefPubMedPubMedCentral
21.
go back to reference Patel R. Venous thromboembolism prophylaxis in mental healthcare: do the benefits outweigh the risks? BJ Psych Bull. 2015;39:61–4. Patel R. Venous thromboembolism prophylaxis in mental healthcare: do the benefits outweigh the risks? BJ Psych Bull. 2015;39:61–4.
Metadata
Title
Venous thromboembolism prophylaxis in mental health in-patient services: a qualitative study
Authors
Audrey Purcell
Mary Clarke
Ian Maidment
Publication date
01-06-2018
Publisher
Springer International Publishing
Published in
International Journal of Clinical Pharmacy / Issue 3/2018
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-018-0599-7

Other articles of this Issue 3/2018

International Journal of Clinical Pharmacy 3/2018 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.